NCT00836407
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Clinical trial condition
Diabetes Mellitus, Insulin-Dependent, 12
Explore clinical trials studying Diabetes Mellitus, Insulin-Dependent, 12. Study availability and eligibility vary by location and protocol.
55 public trials
8 recruiting studies
Diabetes Mellitus, Insulin-Dependent, 12 trial results
NCT02705482
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms, Select Advanced Solid Tumors
- Locations
-
- Research Site Santa Monica, California, United States
- Research Site Chicago, Illinois, United States
- Research Site St Louis, Missouri, United States
- Research Site Albuquerque, New Mexico, United States
NCT03549546
- Conditions
- Cytopenia, Diabetes Mellitus, Insulin-Dependent, 12, Hematologic Diseases, +15 more
- Locations
-
- CHU Saint-Etienne Saint-Etienne, France
NCT01331525
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Diabetes Mellitus, Insulin-Dependent, 12, +9 more
- Locations
-
- Royal Bournemouth Hospital Bournemouth, United Kingdom
- Leeds Teaching Hospitals NHS Foundation Trust Leeds, United Kingdom
- Barts and The London NHS Trust London, United Kingdom
- The Clatterbridge Cancer Centre NHS Foundation Trust Metropolitan Borough of Wirral, United Kingdom
NCT00028431
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +10 more
- Locations
-
- Universtiy of Southern California/Kenneth Norris, Jr. Comprehensive Cancer Center Los Angeles, California, United States
Active, Not Recruiting
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma
NCT01843374
- Conditions
- Adenoma, Diabetes Mellitus, Insulin-Dependent, 12, Lung Diseases, +13 more
- Locations
-
- Research Site Scottsdale, Arizona, United States
- Research Site La Jolla, California, United States
- Research Site Los Angeles, California, United States
- Research Site San Francisco, California, United States
Active, Not Recruiting
Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer
NCT05426005
- Conditions
- Colonic Diseases, Colorectal Cancer Stage IV, Colorectal Neoplasms, +13 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Active, Not Recruiting
Combination Immunotherapy in Colorectal Cancer
NCT05571293
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +9 more
- Locations
-
- Weill Cornell Medicine/New York-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
- Weill Cornell Medicine/NewYork Presbyterian - Queens Flushing, New York, United States
- Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
Active, Not Recruiting
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
NCT03530397
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms, Selected Advanced Solid Tumors
- Locations
-
- Research Site Detroit, Michigan, United States
- Research Site New York, United States
- Research Site Chapel Hill, North Carolina, United States
- Research Site Providence, Rhode Island, United States
Active, Not Recruiting
A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC
NCT07000149
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Aurora, Colorado, United States
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States